Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2004
08/26/2004WO2004044247A3 One step real-time rt pcr kits for the universal detection of organisms in industrial products
08/26/2004WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof
08/26/2004WO2004044141A8 Conjugated oligomeric compounds and their use in gene modulation
08/26/2004WO2004042070A3 Electrical detection of dna hybridization and specific binding events
08/26/2004WO2004035819A3 Oligonucleotide analogues for detecting and analyzing nucleic acids
08/26/2004WO2004033660A3 Gene expression profiling from ffpe samples
08/26/2004WO2004033649A3 High throughput multiplex dna sequence amplifications
08/26/2004WO2004031208A3 Promoter sequences for corticotropin releasing factor binding protein and use thereof
08/26/2004WO2004020968A3 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
08/26/2004WO2004020664A3 Polymorphous microsatellite loci in genes for pre-diagnostic purposes
08/26/2004WO2004020662A3 Method and nucleic acids for the analysis of breast cell proliferative disorders
08/26/2004WO2004020607A3 SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER
08/26/2004WO2004019002A3 Fluorescent glycosides and methods for their use
08/26/2004WO2004018992A3 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same
08/26/2004WO2004018708A3 Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
08/26/2004WO2004018706A3 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
08/26/2004WO2004016755A3 Amplification of target nucleotide sequence without polymerase chain reaction
08/26/2004WO2004015127A3 Anticodon-based libraries and molecules for the specific shotgun and/or direct targeting of, and/or interaction with cells, tissues, surfaces, materials, molecules, and energy fields
08/26/2004WO2004013305A3 Improved compositions for in vitro amplification of nucleic acids
08/26/2004WO2004010106A3 METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
08/26/2004WO2004005466A3 Methods and compositions for diagnosing hepatocellular carcinoma
08/26/2004WO2003102544A3 Assays for measuring matrix metalloproteinase activities
08/26/2004WO2003095475A3 Peptide compounds and their use as protease substrates
08/26/2004WO2003093411A3 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
08/26/2004WO2003092627A3 High throughput screening assay for detecting a dna sequence
08/26/2004WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/26/2004WO2003091399A3 Production and use of salt tolerant and culture density tolerant organisms
08/26/2004WO2003087051A3 Methods for identifying allosteric sites
08/26/2004WO2003056343A3 Method for protein expression analysis
08/26/2004WO2003056030A3 Methods and systems of nucleic acid sequencing
08/26/2004WO2003055440A3 Compositions and methods for the treatement of immune related diseases
08/26/2004WO2003040388A3 Method for detecting bacteria associated with parodontitis and tooth decay
08/26/2004WO2003035843A3 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
08/26/2004WO2003035829A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
08/26/2004WO2003002633A9 Synthesis and use of organosilica particles
08/26/2004WO2002090562A3 Methods for the reduction of stutter in microsatellite amplification
08/26/2004WO2002030268A3 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
08/26/2004US20040168212 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
08/26/2004US20040168210 for drug screening anticancer/osteoporosis agents; animal models; genetic engineering
08/26/2004US20040168209 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
08/26/2004US20040167214 Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
08/26/2004US20040167213 Administering enzyme inhibitor; side effect reduction
08/26/2004US20040167196 Treatment of benign prostatic hyperplasia
08/26/2004US20040167091 Methods for treating ocular neovascular diseases
08/26/2004US20040167089 Immunostimulatory nucleic acid molecules
08/26/2004US20040167075 Diagnosis, therapy od Alzheimer's disease; blocking psychological conditions
08/26/2004US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases
08/26/2004US20040167064 Materials and methods relating for the treatment and diagnosis of pre-eclampsia
08/26/2004US20040166577 for preparing samples submergible in a liquid medium; improves one by one experimentation through enhancing the detection sensitivity; for rapid drug screening
08/26/2004US20040166574 Microorganism John Antonius (MJA) found in humans that have gastrointestinal diseases such as colitis; kits
08/26/2004US20040166565 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors
08/26/2004US20040166564 D-aminoacylase and gene encoding the same
08/26/2004US20040166561 Novel intein and uses thereof
08/26/2004US20040166557 comprising a mixture of a carbohydrate, a pH indicator dye responsive to the presence of beta-galactosidase; chromogenic substrate enhancer
08/26/2004US20040166554 Method for assaying the activity of lysosomal enzymes
08/26/2004US20040166553 Caged sensors, regulators and compounds and uses thereof
08/26/2004US20040166545 for drug screening using newly designed vectors coding for marker proteins and transfected cells; for high throughput assays
08/26/2004US20040166543 Regulation of cell growth by MUC1
08/26/2004US20040166539 Signalling compounds and methods for detecting hydrogen peroxide
08/26/2004US20040166529 Comprises electrophoretic tag (e-tag) probes for the multiplexed detection of binding or interactions between one or more ligands and target antiligands; biomolecular marker and signal resolution
08/26/2004US20040166528 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
08/26/2004US20040166527 Compositions and methods for the identification of lung tumor cells
08/26/2004US20040166526 Gene cloning
08/26/2004US20040166524 Method and device for purifying nucleic acids
08/26/2004US20040166522 Microarray, method for producing the same, and method for correcting inter-PIN spotting amount error of the same
08/26/2004US20040166521 Methods and composition for diagnosing and treating Pseudoxanthoma elasticum and related conditions
08/26/2004US20040166520 Using nucleic acid probes as tools in forensic identification of coded items; anticounterfeiting
08/26/2004US20040166519 Using single nucleotide polymorphisms to diagnose cardiovascular and vascular disorders
08/26/2004US20040166518 Multilabeling mouse FISH assay for detecting structural and numerical chromosomal abnormalities
08/26/2004US20040166516 Providing a candidate catalytic protein fusion molecule, including a catalytic protein linked to both its nucleic acid coding sequence and a substrate; determining whether candidate catalytic protein catalyzes a reaction of the substrate by assaying for an alteration in molecular size, charge etc.
08/26/2004US20040166514 Using fluorescent intensity to monitor and analyze molecular interations of target nucleotide sequences; identifying molecules, molecular interactions and complexes by direct detection of association with one or more probes
08/26/2004US20040166513 Enhancing accuracy of determining DNA concentration after cyclic replication; gene expression analysis using polymerase chain reaction
08/26/2004US20040166511 Using multiplex DNA amplification to diagnose, classify and prognose tumor or viral related diseases
08/26/2004US20040166510 Comprises plant enzymatic polypeptide associated with modifiying DNA; screening and identifying mismatched double stranded nucleotide sequences
08/26/2004US20040166509 Detecting hormonally active compounds
08/26/2004US20040166508 determined qualitatively and/or quantitatively from the relative amount of the changes in said opto-electronic signals; solid phase synthesis
08/26/2004US20040166507 Comprises nucleotide sequences coding aspartyl protease for identifying modulators for treatment of nervous system disorders; enzyme inhibitors
08/26/2004US20040166506 Methods and compositions for genotyping
08/26/2004US20040166503 Using amplified differential gene expression (ADGE) to identify transcriptional variations and mutations that generate drug resistant tumor cells
08/26/2004US20040166498 Preparing nucleotide sequences for use as probes in genetic analysis; restriction fragment length polymorphisms; biopolymer sequence determination
08/26/2004US20040166495 Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip
08/26/2004US20040166493 Identifying allelic variation in nucleotide sequences using heteroduplex DNA, glycosylase cleavage and dideoxynucleotide sequencing
08/26/2004US20040166492 Quantitative detection of dekkera and saccharomyces
08/26/2004US20040166491 Using restriction fragment length polymorphism in von Hippel-Lindau syndrome tumor suppressor gene to diagnose cell proliferative, neurodegenerative, autoimmune, cardiovascular and respiratory disorders
08/26/2004US20040166490 Comprises nucleotide sequences coding cancer associated protein (CA protein) for use in diagnosis, prevention and treatment of cell proliferative disorders
08/26/2004US20040166487 Automated rinse water and body fluid bioagent detection
08/26/2004US20040166485 for in vitro cell culture methods to produce precursor steroids and in vivo treatments for disease states involving the biosynthetic pathway; genetic engineering
08/26/2004US20040166199 Containing fatty ester; desterification using esterase
08/26/2004US20040166183 Methods and means for preventing or treating inflammation or pruritis
08/26/2004US20040166162 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
08/26/2004US20040166117 Overexpression of protease hepsin; induce immunology response; inoculation with hepsin peptide; monitoring immunotherapy
08/26/2004US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
08/26/2004US20040166105 Compositions and methods relating to breast specific genes and proteins
08/26/2004US20040166099 Molecules preferentially associated with effector T cells and methods of their use
08/26/2004US20040166025 including nucleic acids containing entire genomes; applying shear forces as polymer moves along a tapered channel from first end to second end; multiple molecules may be stretched in succession allowing high throughput screening
08/26/2004US20040163953 Biosensor
08/26/2004DE10307732A1 New oligonucleotides for specific detection of microorganisms, useful e.g. for detecting or quantifying microbes on the skin, in foods, clinical samples or water, by in situ hybridization
08/26/2004DE10306616A1 Kit for detection of microorganisms on skin, useful e.g. for diagnosis of infection, comprises specific oligonucleotides for in situ hybridization
08/26/2004DE10305213A1 Verwendung eines neuen Polymorphismus im hsgk1-Gen zur Diagnose der Hypertonie und Verwendung der sgk-Genfamilie zur Diagnose und Therapie des Long-Q/T-Syndroms Use of a new polymorphism in the gene hsgk1 for diagnosing hypertension and use of the sgk gene family for the diagnosis and therapy of the Long-Q / T syndrome
08/26/2004DE10304660A1 Method of screening for pain-regulating compounds, useful for therapy and diagnosis, based on their ability to bind to specific nucleic acid sequences or proteins, identified as being pain regulated